Joseph Fargnoli
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Cancer, Lipids, and Metabolism, Cancer, Hypoxia, and Metabolism, HER2/EGFR in Cancer Research, Metabolomics and Mass Spectrometry Studies
Most-Cited Works
- → Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents.(1989)689 cited
- → Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy(2011)275 cited
- → Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily(2009)275 cited
- → Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement.(1994)247 cited
- → Decreased expression of heat shock protein 70 mRNA and protein after heat treatment in cells of aged rats.(1990)228 cited
- → Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma(2008)